Watch and wait in rectal cancer: is it time to subclassify cT3?

Affiliations

Comment

Rob Glynne-Jones. Lancet Gastroenterol Hepatol. 2018 Dec.

. 2018 Dec;3(12):814-815.

doi: 10.1016/S2468-1253(18)30309-1. Epub 2018 Oct 12.

¹ Mount Vernon Centre for Cancer Treatment, London HA6 2RN, UK. Electronic address: rob.glynnejones@nhs.net.

No abstract available

Comment on

Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Sun Myint A, Smith FM, Saunders MP, Scott N, O'Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Sao Julião G, Perez R, Renehan AG. Chadi SA, et al. Lancet Gastroenterol Hepatol. 2018 Dec;3(12):825-836. doi: 10.1016/S2468-1253(18)30301-7. Epub 2018 Oct 12. Lancet Gastroenterol Hepatol. 2018. PMID: 30318451